Today, NICE has published an update to their Suspected Cancer (CG27) guideline.

The guideline has been updated to encourage a far greater number of patients to be referred for urgent cancer assessment and investigations to improve earlier diagnosis.

Map of Medicine Clinical Director, Dr Andrew Jones said: “Map of Medicine continuously monitors for changes in the evidence and best practice guidance, so we have been aware that these new recommendations from NICE were due to be updated. Our Clinical Editors are already working to update a number of Map of Medicine pathways with the new recommendations. This guideline will have a significant impact on suspected cancer pathway referrals and will likely impact urgent direct access diagnostic services. It is important that Clinical Commissioning Groups (CCGs) consider how they will implement the Suspected Cancer guidance from NICE across their local health community, and support their local GPs to provide care in line with current best practice.”

Our team of clinical and editorial experts work with CCGs every day to implement national and local guidance. If you need support in reviewing or updating your local care pathways then please contact us for an informal conversation about how we can help.